158 related articles for article (PubMed ID: 27436025)
1. Should fat in the radiofrequency ablation zone of hepatocellular adenomas raise suspicion for residual tumour?
Costa AF; Kajal D; Pereira A; Atri M
Eur Radiol; 2017 Apr; 27(4):1704-1712. PubMed ID: 27436025
[TBL] [Abstract][Full Text] [Related]
2. Fatty hepatocellular carcinoma: radiofrequency ablation--imaging findings.
Pupulim LF; Hakimé A; Barrau V; Abdel-Rehim M; Zappa M; Vilgrain V
Radiology; 2009 Mar; 250(3):940-8. PubMed ID: 19164699
[TBL] [Abstract][Full Text] [Related]
3. Does intra-tumoural fat on MRI predict visibility of small (≤3 cm) hepatocellular carcinomas during ultrasound-guided tumour ablation?
Hui TCH; Huang IKH; Lau WK; Pua U
Clin Radiol; 2018 Mar; 73(3):254-258. PubMed ID: 29129265
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of radiofrequency ablation for hepatocellular adenoma.
van Vledder MG; van Aalten SM; Terkivatan T; de Man RA; Leertouwer T; Ijzermans JN
J Vasc Interv Radiol; 2011 Jun; 22(6):787-93. PubMed ID: 21616431
[TBL] [Abstract][Full Text] [Related]
5. [Hepatocellular adenoma treated with radiofrequency ablation in young male].
Kim TY; Kim BS; Hyun CL; Song BC
Korean J Gastroenterol; 2011 Jun; 57(6):384-7. PubMed ID: 21694493
[No Abstract] [Full Text] [Related]
6. Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience.
Garcovich M; Faccia M; Meloni F; Bertolini E; de Sio I; Calabria G; Francica G; Vidili G; Riccardi L; Zocco MA; Ainora ME; Ponziani FR; De Gaetano AM; Gasbarrini A; Rapaccini GL; Pompili M
J Ultrasound; 2019 Jun; 22(2):157-165. PubMed ID: 30306412
[TBL] [Abstract][Full Text] [Related]
7. Imaging Features of Radiofrequency Ablation with Heat-Deployed Liposomal Doxorubicin in Hepatic Tumors.
Hong CW; Chow L; Turkbey EB; Lencioni R; Libutti SK; Wood BJ
Cardiovasc Intervent Radiol; 2016 Mar; 39(3):409-16. PubMed ID: 26228246
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of multiple hepatocellular adenomas with percutaneous radiofrequency ablation.
Ahn SY; Park SY; Kweon YO; Tak WY; Bae HI; Cho SH
World J Gastroenterol; 2013 Nov; 19(42):7480-6. PubMed ID: 24259982
[TBL] [Abstract][Full Text] [Related]
9. Long-term Evolution of Hepatocellular Adenomas at MRI Follow-up.
Vernuccio F; Ronot M; Dioguardi Burgio M; Cauchy F; Choudhury KR; Dokmak S; Soubrane O; Valla D; Zucman-Rossi J; Paradis V; Vilgrain V
Radiology; 2020 May; 295(2):361-372. PubMed ID: 32181728
[TBL] [Abstract][Full Text] [Related]
10. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
[TBL] [Abstract][Full Text] [Related]
11. Letter to the Editor re: Should fat in the radiofrequency ablation zone of hepatocellular adenomas raise suspicion for residual tumour?
Ronot M; Benzimra J; Bouda D; Vilgrain V
Eur Radiol; 2017 Jun; 27(6):2235-2236. PubMed ID: 27757520
[No Abstract] [Full Text] [Related]
12. Magnetic resonance imaging with gadoxetic acid for local tumour progression after radiofrequency ablation in patients with hepatocellular carcinoma.
Kang TW; Rhim H; Lee J; Song KD; Lee MW; Kim YS; Lim HK; Jang KM; Kim SH; Gwak GY; Jung SH
Eur Radiol; 2016 Oct; 26(10):3437-46. PubMed ID: 26747262
[TBL] [Abstract][Full Text] [Related]
13. Reply to Letter to the Editor re: Should fat in the radiofrequency ablation zone of hepatocellular adenomas raise suspicion for residual tumour?
Costa AF; Atri M
Eur Radiol; 2017 Jun; 27(6):2237-2238. PubMed ID: 27766384
[No Abstract] [Full Text] [Related]
14. Radiofrequency Ablation of Liver Tumors: No Difference in the Ablation Zone Volume Between Cirrhotic and Healthy Liver.
Cassinotto C; Denys A; Gay F; Duran R; Hocquelet A; Piron L; Guiu B
Cardiovasc Intervent Radiol; 2018 Jun; 41(6):905-911. PubMed ID: 29484466
[TBL] [Abstract][Full Text] [Related]
15. New MRI features improve subtype classification of hepatocellular adenoma.
Bise S; Frulio N; Hocquelet A; Alberti N; Blanc JF; Laurent C; Laumonier H; Balabaud C; Bioulac-Sage P; Trillaud H
Eur Radiol; 2019 May; 29(5):2436-2447. PubMed ID: 30523457
[TBL] [Abstract][Full Text] [Related]
16. Microwave Ablation for the Treatment of Hepatic Adenomas.
Smolock AR; Cristescu MM; Potretzke TA; Ziemlewicz TJ; Lubner MG; Hinshaw JL; Brace CL; Lee FT
J Vasc Interv Radiol; 2016 Feb; 27(2):244-9. PubMed ID: 26830938
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of in silico planning and real-time simulation of hepatic radiofrequency ablation (ClinicIMPPACT Trial).
Moche M; Busse H; Futterer JJ; Hinestrosa CA; Seider D; Brandmaier P; Kolesnik M; Jenniskens S; Blanco Sequeiros R; Komar G; Pollari M; Eibisberger M; Portugaller HR; Voglreiter P; Flanagan R; Mariappan P; Reinhardt M
Eur Radiol; 2020 Feb; 30(2):934-942. PubMed ID: 31471752
[TBL] [Abstract][Full Text] [Related]
18. MR imaging of hepatocellular adenomas on genotype-phenotype classification: A report from China.
Wang H; Yang C; Rao S; Ji Y; Han J; Sheng R; Zeng M
Eur J Radiol; 2018 Mar; 100():135-141. PubMed ID: 29496071
[TBL] [Abstract][Full Text] [Related]
19. Imaging findings after radiofrequency ablation of adrenal tumors.
Brook OR; Mendiratta-Lala M; Brennan D; Siewert B; Faintuch S; Goldberg SN
AJR Am J Roentgenol; 2011 Feb; 196(2):382-8. PubMed ID: 21257891
[TBL] [Abstract][Full Text] [Related]
20. Mid-term outcome of positron emission tomography/computed tomography-assisted radiofrequency ablation in primary and secondary liver tumours--a single-centre experience.
Kuehl H; Stattaus J; Hertel S; Hunold P; Kaiser G; Bockisch A; Forsting M
Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):234-40. PubMed ID: 18155453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
